Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application
出版年份 2022 全文链接
标题
Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application
作者
关键词
-
出版物
CANCER LETTERS
Volume 546, Issue -, Pages 215840
出版商
Elsevier BV
发表日期
2022-07-31
DOI
10.1016/j.canlet.2022.215840
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
- (2021) Noam Levin et al. CLINICAL CANCER RESEARCH
- A deep learning model for predicting next-generation sequencing depth from DNA sequence
- (2021) Jinny X. Zhang et al. Nature Communications
- Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
- (2021) Fernanda G Herrera et al. Cancer Discovery
- Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
- (2021) Vid Leko et al. Journal for ImmunoTherapy of Cancer
- Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
- (2020) Parisa Malekzadeh et al. CLINICAL CANCER RESEARCH
- Neoantigens in Hematologic Malignancies
- (2020) Melinda A. Biernacki et al. Frontiers in Immunology
- NK cells specifically TCR-dressed to kill cancer cells
- (2019) Nadia Mensali et al. EBioMedicine
- Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
- (2019) Elizabeth I. Buchbinder et al. Journal for ImmunoTherapy of Cancer
- Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
- (2019) Winifred Lo et al. Cancer Immunology Research
- iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
- (2019) Naiqing Ding et al. Nature Communications
- Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
- (2019) Justine Habault et al. MOLECULES
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy
- (2019) Anthony Tanoto Tan et al. GASTROENTEROLOGY
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations
- (2019) Joshua R. Veatch et al. Cancer Immunology Research
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- TCR-like antibodies in cancer immunotherapy
- (2019) Qinghua He et al. Journal of Hematology & Oncology
- Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
- (2019) Lionel Low et al. Nature Communications
- Peptide‐MHC class I and class II tetramers: From flow to mass cytometry
- (2019) Asbjørn Christophersen HLA
- Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement
- (2018) Qiuping Xu et al. CELLULAR IMMUNOLOGY
- T-cell responses toTP53"hotspot" mutations and unique neoantigens expressed by human ovarian cancers
- (2018) Drew C Deniger et al. CLINICAL CANCER RESEARCH
- Cell-based molecularly targeted therapy: targeting oncoproteins with T cell receptor gene therapy
- (2018) Christian S. Hinrichs JOURNAL OF CLINICAL INVESTIGATION
- Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
- (2018) Jianjian Jin et al. Journal of Translational Medicine
- Driving T-cell immunotherapy to solid tumors
- (2018) Ken Garber NATURE BIOTECHNOLOGY
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
- (2018) Jane Harper et al. PLoS One
- CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
- (2018) Hannah M. Knochelmann et al. Frontiers in Immunology
- A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
- (2018) Yiyang Xu et al. Cell Discovery
- The role of the tumour microenvironment in immune therapy
- (2017) Stephan Gasser et al. ENDOCRINE-RELATED CANCER
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
- (2017) Jung Min Shin et al. JOURNAL OF CONTROLLED RELEASE
- Shared cancer neoantigens: Making private matters public
- (2017) Christopher A. Klebanoff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
- (2017) Zinal S. Chheda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
- (2017) Daniel T. Harris et al. JOURNAL OF IMMUNOLOGY
- T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
- (2017) Robert Sackstein et al. LABORATORY INVESTIGATION
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Peptide–MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
- (2017) Santiswarup Singha et al. Nature Nanotechnology
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
- (2017) Miles A. Miller et al. Science Translational Medicine
- Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
- (2017) M. Fehlings et al. Nature Communications
- Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies
- (2017) Ryan J. Hartmaier et al. Genome Medicine
- Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice
- (2016) Herbert W. Kavunja et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+T Cell Migration into Tumors
- (2016) Zinal S. Chheda et al. JOURNAL OF IMMUNOLOGY
- Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
- (2016) Drew C Deniger et al. MOLECULAR THERAPY
- Expanding antigen-specific regulatory networks to treat autoimmunity
- (2016) Xavier Clemente-Casares et al. NATURE
- Neoantigen landscape dynamics during human melanoma–T cell interactions
- (2016) Els M. E. Verdegaal et al. NATURE
- Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes
- (2016) Amalie Kai Bentzen et al. NATURE BIOTECHNOLOGY
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer
- (2015) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Mutation-Specific T Cells for Immunotherapy of Gliomas
- (2015) Cornelis J.M. Melief NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- Epstein–Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells
- (2015) Anindita Deb Pal et al. VIROLOGY
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
- (2014) Y.-C. Lu et al. CLINICAL CANCER RESEARCH
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
- (2014) Paul F. Robbins et al. JOURNAL OF IMMUNOLOGY
- Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
- (2014) Jens G Lohr et al. NATURE BIOTECHNOLOGY
- Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
- (2014) Faviel F. González-Galarza et al. NUCLEIC ACIDS RESEARCH
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Use of the piggyBac Transposon to Create Stable Packaging Cell Lines for the Production of Clinical-Grade Self-Inactivating γ-Retroviral Vectors
- (2014) Steven A. Feldman et al. Human Gene Therapy Methods
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
- (2012) Daisuke Nobuoka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The cancer antigenome
- (2012) Bianca Heemskerk et al. EMBO JOURNAL
- T-cell-receptor-like antibodies – generation, function and applications
- (2012) Rony Dahan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials
- (2010) J. L. Davis et al. CLINICAL CANCER RESEARCH
- Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
- (2010) Sue Tsai et al. IMMUNITY
- Molecular immunology lessons from therapeutic T-cell receptor gene transfer
- (2010) Sharyn Thomas et al. IMMUNOLOGY
- Epigenetic Mechanisms Regulate MHC and Antigen Processing Molecules in Human Embryonic and Induced Pluripotent Stem Cells
- (2010) Beatriz Suárez-Álvarez et al. PLoS One
- Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition
- (2008) S Yang et al. GENE THERAPY
- Molecular Design of Coumarin Dyes for Stable and Efficient Organic Dye-Sensitized Solar Cells
- (2008) Zhong-Sheng Wang et al. Journal of Physical Chemistry C
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started